JAB-23E73 in Adult Participants With Advanced Solid Tumors With KRAS Alteration
JAB-23E73 in Adult Participants With Advanced Solid Tumors With KRAS Alteration
Recruiting · NCT06973564 · Registry updated 2026-01-16Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| JAB-23E73 in Adult Participants With Advanced Solid Tumors With KRAS Alteration | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, colonic disorder, colorectal neoplasm, digestive system disorder, digestive system neoplasm, endocrine system disorder, intestinal disorder, malignant endocrine neoplasm, neoplasm, pancreas disorder, pancreatic neoplasm, rectal disorder | Recruiting | Phase 1 / Phase 2 | 2026-01-16 | NCT06973564 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Jacobio Pharmaceuticals Co., Ltd. | 7 |
4 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Cleveland Clinic Foundation | Cleveland | United States | 370 |
| Huntsman Cancer Institute | Salt Lake City | United States | 107 |
| Mayo Clinic | Rochester | United States | 664 |
| Washington University | St Louis | United States | 182 |